Epidemiologic features of chronic atrial fibrillation: The framingham study, N Engl J Med, vol.306, pp.1018-1040, 1982. ,
Epidemiology and natural history of atrial fibrillation: clinical implication, J Am Coll Cardiol, vol.37, pp.371-379, 2001. ,
Rantaharjin PM for the CHS collaborative research group. Prevalence of the atrial fibrillation in elderly subjects. The cardiovascular heart study, Am J Cardiol, vol.74, pp.236-277, 1994. ,
Role of dispersion of atrial refractoriness in the recurrence of atrial fibrillation. A manifestation of atrial electrical remondelling in humans?, Eur Heart J, vol.22, pp.1822-1856, 2001. ,
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, vol.98, pp.946-952, 1998. ,
A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study, Am J Med, vol.113, pp.359-364, 2002. ,
All-cause mortality in 272,186 patients hospitalized withincident atrial fibrillation 1995-2008: a Swedish nationwide long-term casecontrol study, Eur Heart J, vol.34, pp.1061-1067, 2013. ,
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N Engl J Med, vol.330, pp.659-66, 1998. ,
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring, JAMA, vol.291, pp.2851-2855, 2004. ,
Familial aggregation of lone atrial fibrillation in young persons, J Am Coll Cardiol, vol.60, pp.917-921, 2012. ,
, Metaanalysis identifies six new susceptibility loci for atrial fibrillation, vol.44, pp.670-675, 2012.
Atrial fibrillation: the role of common and rare genetic variants, Eur J Hum Genet, vol.22, pp.297-306, 2014. ,
Integrating genetic, transcriptional, and functional analyses to to identify 5 novel genes for atrial fibrillation, Circulation, vol.130, pp.1225-1235, 2014. ,
Variants conferring risk of atrial fibrillation on chromosome 4q25, Nature, vol.448, pp.353-357, 2007. ,
Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese, J Am Coll Cardiol, vol.63, pp.1200-1210, 2014. ,
Shedding new light on the pathophysiology of conversion of paroxysmal atrial fibrillationinto parsistant atrial fibrillation, Am Heart J, vol.154, pp.801-805, 2007. ,
Atrial fibrillation begets atrial fibrillation. A study in awakechronically instrumented goats, Circulation, vol.92, pp.1454-68, 1995. ,
Pathophysiology and prevention of atrial fibrillation, Circulation, vol.103, pp.764-77, 2001. ,
The gap junctional prote in connexion. 40 is elevated in patients susceptible to postoperative atrial fibrillation, Circulation, vol.103, pp.842-851, 2001. ,
Role of gender and personality on quality of life impairment in intermittant atrial fibrillation, Am Heart J, vol.118, pp.913-921, 1989. ,
The college of French cardiologists. Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA study, Circulation, vol.99, pp.3028-3063, 1999. ,
Alcohol consumption and rick and prognosis of atrial fibrillation among older adults: the cardiovascular study, Am Heart J, vol.153, pp.260-266, 2007. ,
Subclinical hyperthyroidism as a risk factor for atrial fibrillation, Am Heart J, vol.142, pp.838-880, 2001. ,
Atrial fibrillation after coronary artery bypass surgery, Circulation, vol.201, pp.1403-1411, 2000. ,
Relation of vigorous exercice to risk of atrial fibrillation, Am J Cardiol, vol.103, pp.1572-1579, 2009. ,
The role of atrial ectopics in initiatings paroxysmal atrial fibrillation, Eur Heart J, vol.22, pp.333-342, 2001. ,
The alternation between atrial flutter and atrial fibrillation, Chest, vol.101, pp.34-40, 1992. ,
Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia, J Am Coll Cardiol, vol.25, pp.984-992, 1995. ,
Spontaneous occurred of symptomatic paroxysmal atrial fibrillation and paroxysmal supra ventricular tachycardia in untreated patients, Circulation, vol.87, pp.1114-1136, 1993. ,
Big men and atrial fibrillation: effects of body sizeand weight gain on risk of atrial fibrillation in men, Eur Heart J, vol.30, pp.11113-11133, 2009. ,
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS, European Heart Journal, vol.37, issue.38, pp.2893-2962, 2016. ,
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2 nd AFNET-EHRA consensus conference 'research perspectives in AF, Eur Heart J, vol.30, pp.2969-2977, 2009. ,
Heart failure epidemiology: European perspective, Curr Cardiol Rev, vol.9, pp.123-127, 2013. ,
What are the costs of heart failure?, Europace, vol.13, pp.13-17, 2011. ,
A review of the cost of atrial fibrillation, Value Health, vol.15, pp.240-248, 2012. ,
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial differences in Stroke (REGARDS) Study, Circ Arrhythm Electrophysiol, vol.4, pp.26-32, 2011. ,
Atrial fibrillation in heart failure: what should we do?, Eur Heart J, vol.36, pp.3250-3257, 2015. ,
Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis, Circ Arrhythm Electrophysiol, vol.7, pp.1011-1018, 2014. ,
Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction, Heart Lung Circ, vol.24, pp.270-280, 2015. ,
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure, N Engl J Med, vol.359, pp.1778-1785, 2008. ,
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis, J Am Coll Cardiol, vol.55, pp.2299-2307, 2010. ,
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a metaanalysis, J Am Coll Cardiol, vol.45, pp.1832-1839, 2005. ,
Prevention of atrial fibrillation by way of abrogation of the reninangiotensin system: a systematic review and meta-analysis, Am J Ther, vol.15, pp.36-43, 2008. ,
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study, Circulation, vol.106, pp.331-336, 2002. ,
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study, Eur Heart J, vol.24, pp.2090-2098, 2003. ,
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, vol.33, pp.2451-2496, 2012. ,
AHA/ ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, vol.63, pp.2438-2488, 2014. ,
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, vol.26, pp.2422-2434, 2005. ,
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur J Cardiothorac Surg, vol.42, pp.1-44, 2012. ,
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study), Am J Cardiol, vol.114, pp.1217-1222, 2014. ,
Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study, Circ Arrhythm Electrophysiol, vol.7, pp.620-625, 2014. ,
Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study), Eur Heart J, vol.27, pp.96-106, 2006. ,
Atrial fibrillation and obesity-results of a meta-analysis, Am Heart J, vol.155, pp.310-315, 2008. ,
Obesity and the risk of new-onset atrial fibrillation, JAMA, vol.292, pp.2471-2477, 2004. ,
Body mass index and adverse events in patients with incident atrial fibrillation, Am J Med, vol.126, pp.640-649, 2013. ,
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY), J Am Coll Cardiol, vol.65, pp.2159-2169, 2015. ,
58-Digby GC, Baranchuk A. Sleep apnea and atrial fibrillation; 2012 update, J Cardiovasc Med, vol.8, pp.265-272, 2012. ,
Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium, Clin Sci (Lond), vol.122, pp.121-132, 2012. ,
Atrial fibrillation in obstructive sleep apnea: atrial arrhythmogenic substrate of a different sort, Am J Cardiol, vol.110, p.1071, 2012. ,
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding), Am J Cardiol, vol.111, pp.1159-1164, 2013. ,
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a twophase study, BMC Health Serv Res, vol.8, p.221, 2008. ,
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?, J Am Heart Assoc, vol.3, p.1179, 2014. ,
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study, J Thromb Haemost, vol.13, pp.495-504, 2015. ,
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation, Ann Intern Med, vol.147, pp.590-592, 2007. ,
Apixaban in patients with atrial fibrillation, AVERROES Steering Committee Investigators, vol.364, pp.806-817, 2011. ,
HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement, Heart Rhythm, vol.12, pp.105-113, 2015. ,
Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry, Thromb Haemost, vol.111, pp.833-841, 2014. ,
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry, Circ Cardiovasc Qual Outcomes, vol.167, pp.624-631, 2010. ,
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin, Circ Cardiovasc Qual Outcomes, vol.6, pp.567-574, 2013. ,
Risk of falls and major bleeds in patients on oral anticoagulation therapy, Am J Med, vol.125, pp.773-778, 2012. ,
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls, Arch Intern Med, vol.159, pp.677-685, 1999. ,
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, Lancet, vol.370, pp.493-503, 2007. ,
AVERROES Steering Committee and Investigators. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial, Lancet Neurol, vol.11, pp.225-231, 2012. ,
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, vol.137, pp.263-272, 2010. ,
Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, vol.365, pp.981-992, 2011. ,
RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, vol.361, pp.1139-1151, 2009. ,
Investigators EA-T. Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, vol.369, pp.2093-2104, 2013. ,
ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, vol.365, pp.883-891, 2011. ,
Left Atrial Appendage Closure as an Alternative toWarfarin for Stroke Prevention in Atrial Fibrillation: A PatientLevel Meta-Analysis, J Am Coll Cardiol, vol.65, pp.2614-2623, 2015. ,
, National Institute for Health and Care Excellence (NICE) guidelines. Atrial fibrillation: management, 2016.
Calcium channel blockers in heart failure, Cardiology, vol.89, pp.38-46, 1998. ,
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group, Circulation, vol.83, pp.52-60, 1991. ,
A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, vol.347, pp.1825-1833, 2002. ,
Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, vol.347, pp.1834-1840, 2002. ,
Investigators of the Polish How to Treat Chronic Atrial Fibrillation Study. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study, Chest, vol.126, pp.476-486, 2004. ,
Is rhythmcontrol superior to rate-control in patients with atrial fibrillation and diastolic heart failure?, Ann Noninvasive Electrocardiol, vol.15, pp.209-217, 2010. ,
Rate and rhythm control have comparable effects on mortality and stroke in atrial fibrillation but better data are needed, Evid Based Med, vol.19, pp.222-223, 2014. ,
Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management, Cardiology, vol.112, pp.270-278, 2009. ,
Comparison of pharmacological and electrical cardioversion in permanent atrial fibrillation after prosthetic cardiac valve replacement: a prospective randomized trial, J Int Med Res, vol.41, pp.1067-1073, 2013. ,
Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study, Clin Res Cardiol, vol.102, pp.713-723, 2013. ,
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebocontrolled trial, Circulation, vol.117, pp.1518-1525, 2008. ,
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial, Circ Arrhythm Electrophysiol, vol.2, pp.313-321, 2009. ,
Systematic reviewand meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation, Cardiovasc Drugs Ther, vol.26, pp.167-179, 2012. ,
Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis, J Am Coll Cardiol, vol.41, pp.255-262, 2003. ,
DOI : 10.1016/s0735-1097(02)02705-5
URL : https://doi.org/10.1016/s0735-1097(02)02705-5
Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach, N Engl J Med, vol.351, pp.2384-2391, 2004. ,
Vernakalantfacilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion, Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial, vol.6, pp.51-56, 1999. ,
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study), Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study, vol.62, pp.501-507, 2013. ,
Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success, Circ Arrhythm Electrophysiol, vol.8, pp.308-317, 2015. ,
,
Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center, Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint, vol.8, pp.724-757, 2002. ,
Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation, Archives of Cardiovascular Diseases, vol.110, issue.4, pp.1008-1022, 2015. ,
Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures, J Interv Card Electrophysiol, vol.31, pp.247-55, 2011. ,
Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a twodimensional myocardial imaging study, J Interv Card Electrophysiol, vol.26, pp.999-1006, 2009. ,
Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation, Eur Heart J, vol.29, pp.1397-409, 2008. ,
Clinical significance ofthe assessment of the systolic and diastolic myocardial functionof the left atrium in patients with paroxysmal atrial fibrilla-tion and low CHADS(2) index treated with catheter ablationtherapy, Am J Cardiol, vol.111, pp.1002-1013, 2013. ,